← Back to Clinical Trials
Recruiting NCT06696677

NCT06696677 Small Intestine Length Measurement Using 3D CT Volumetry and in Vivo Measurement Using Pre-marked Graspers in Revisional Bariatric Surgeries. A Comparative Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06696677
Status Recruiting
Phase
Sponsor Kasr El Aini Hospital
Condition Small Intestine Length
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-01-26
Primary Completion 2025-07-30

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
CTMeasuring the small instestine length using pre-marked laparoscopic graspers

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-01-26 with a primary completion date of 2025-07-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Measuring bowel length during hypo-absorptive surgeries like Roux-en-Y gastric bypass (RYGB) and Single Anastomosis Duodeno-ileal Sleeve (SADI-s) is controversial and usually abandoned due to the high risk of intestinal injury. However, some surgeons, especially in revisional surgery, prefer to count the whole bowel length to avoid leaving very short segments and severe malnutrition afterwards. 3D reconstructed CT scan can be useful in such conditions, avoiding the risk of intestinal injury, but accurate measures might be doubtful.

Eligibility Criteria

Inclusion Criteria: * Patients who are candidates for revisional bariatric surgery * Patients consenting to participate in the study. Exclusion Criteria: * Patients with severe adhesions where measuring the small bowel may expose them to unnecessary injuries. * Patients refusing to participate in the study. * Patient refusing CT scan to be done pre-operatively.

Contact & Investigator

Central Contact

Ahmed Mohammed Abdelsalam, MD, MRCS

✉ a.abd.elsalam@kasralainy.edu.eg

📞 +201111577188

Frequently Asked Questions

Who can join the NCT06696677 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, up to 70 Years, studying Small Intestine Length. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06696677 currently recruiting?

Yes, NCT06696677 is actively recruiting participants. Contact the research team at a.abd.elsalam@kasralainy.edu.eg for enrollment information.

Where is the NCT06696677 trial being conducted?

This trial is being conducted at Cairo, Egypt, Cairo, Egypt.

Who is sponsoring the NCT06696677 clinical trial?

NCT06696677 is sponsored by Kasr El Aini Hospital. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology